Dissemin is shutting down on January 1st, 2025

Published in

АБВ-пресс, Nervno-Mysecnye Bolezni, 4(11), p. 26-33, 2021

DOI: 10.17650/2222-8721-2021-11-4-26-33

Links

Tools

Export citation

Search in Google Scholar

Inflammatory Neuropathy Cause and Treatment (INCAT) Scale for the assessment of disability level in patients with chronic inflammatory demyelinating polyneuropathy: linguocultural ratification in Russia

Journal article published in 2021 by А. S. Arestova, Е. А. Melnik ORCID, A. B. Zaytsev ORCID, A. A. Zimin ORCID, А. Yakubu ORCID, E. S. Sherbakova ORCID, D. G. Yusupova ORCID, D. A. Grishina ORCID, N. A. Suponeva ORCID, M. A. Piradov ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background. Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable dysimmune polyneuropathy. An objective response for pathogenic therapy is essential in diagnosis and management of CIDP. For proper assessment of patient’s complaints and evaluation of disease progression, it is recommended to use validated scales and questionnaires. The paper presents the results of the first step of Inflammatory Neuropathy Cause and Treatment (INCAT) validation in patients with CIDP.Objective: the development of the Russian version of the INCAT scale and its linguocultural ratification.Materials and methods. 15 patients with definite CIDP (according to EFNS/PNS criteria) were enrolled. Linguocultural ratification was conducted according to the standard protocol.Results. The Russian version of the INCAT scale was developed.Conclusion. We conducted the first stage of INCAT scale validation in patients with CIDP.